TRIM21 and gastric cancer: This, in turn, had been found to increase the susceptibility of gastric cancer cells to apatinib treatment in vivo using male nude mice subcutaneously injected with SGC7901 cells, which is capable of inhibiting gastric cancer development, suggesting the potential therapeutic value of TRIM21 in gastric cancer [174,175,176].